ABVC (ABVC BioPharma, Inc. Common Stock) Stock Analysis - Analyst Ratings

ABVC BioPharma, Inc. Common Stock (ABVC) is a publicly traded Healthcare sector company. As of May 21, 2026, ABVC trades at $1.10 with a market cap of $27.43M and a P/E ratio of -2.67. ABVC moved +1.82% today. Year to date, ABVC is -53.19%; over the trailing twelve months it is -19.71%. Its 52-week range spans $0.40 to $5.48. Rallies surfaces ABVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ABVC?

The average price target is $0.00.

ABVC Key Metrics

Key financial metrics for ABVC
MetricValue
Price$1.10
Market Cap$27.43M
P/E Ratio-2.67
EPS$-0.39
Dividend Yield0.29%
52-Week High$5.48
52-Week Low$0.40
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-8.38M
Gross Margin0.00%

ABVC Analyst Consensus

ABVC analyst coverage data. Average price target: $0.00.

Latest ABVC News

Common questions about ABVC

What do analysts rate ABVC?
The average price target is $0.00.
Does Rallies show ABVC price targets?
Yes. Rallies tracks ABVC analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ABVC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ABVC. It does not provide personalized investment advice.
ABVC

ABVC